These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1360 related items for PubMed ID: 25573287
21. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP. J Clin Oncol; 2012 Jul 01; 30(19):2340-7. PubMed ID: 22585703 [Abstract] [Full Text] [Related]
22. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing. Kohlmann A, Bacher U, Schnittger S, Haferlach T. Leuk Lymphoma; 2014 Aug 01; 55(8):1725-34. PubMed ID: 24144312 [Abstract] [Full Text] [Related]
23. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7. Side LE, Curtiss NP, Teel K, Kratz C, Wang PW, Larson RA, Le Beau MM, Shannon KM. Genes Chromosomes Cancer; 2004 Mar 01; 39(3):217-23. PubMed ID: 14732923 [Abstract] [Full Text] [Related]
24. Mutational profiling in patients with MDS: ready for every-day use in the clinic? Bacher U, Kohlmann A, Haferlach T. Best Pract Res Clin Haematol; 2015 Mar 01; 28(1):32-42. PubMed ID: 25659728 [Abstract] [Full Text] [Related]
27. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW, Burke C, Hayde J, Walshe J, McDermott R, Desmond R, McHugh J, Enright H. Hematology; 2017 Jul 01; 22(6):341-346. PubMed ID: 28196450 [Abstract] [Full Text] [Related]
28. Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China. Li J, Pei L, Liang S, Xu S, Wang Y, Wang X, Liao Y, Zhan Q, Cheng W, Yang Z, Tang X, Zhang H, Xiao Q, Chen J, Liu L, Wang L. Cancer Med; 2023 Apr 01; 12(8):9332-9350. PubMed ID: 36799265 [Abstract] [Full Text] [Related]
29. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML. Kim YG, Cho SY, Park TS, Oh SH, Yoon HJ. Ann Clin Lab Sci; 2011 Apr 01; 41(1):79-83. PubMed ID: 21325260 [Abstract] [Full Text] [Related]
30. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype, TP53 deletion, and TP53 mutations. Wang N, Yuan L, Jing Y, Fan K, Jin H, Lv C, Wang L, Yu L. Leuk Lymphoma; 2021 Oct 01; 62(10):2466-2474. PubMed ID: 33904352 [Abstract] [Full Text] [Related]
31. An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling. Flach J, Dicker F, Schnittger S, Schindela S, Kohlmann A, Haferlach T, Kern W, Haferlach C. Leukemia; 2011 Apr 01; 25(4):713-8. PubMed ID: 21233836 [No Abstract] [Full Text] [Related]
32. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome. Au WY, Fung AT, Ma ES, Liang RH, Kwong YL. Cancer Genet Cytogenet; 2004 Mar 01; 149(2):169-72. PubMed ID: 15036894 [Abstract] [Full Text] [Related]
33. Distinct Mutation Landscapes Between Acute Myeloid Leukemia With Myelodysplasia-Related Changes and De Novo Acute Myeloid Leukemia. Gao Y, Jia M, Mao Y, Cai H, Jiang X, Cao X, Zhou D, Li J. Am J Clin Pathol; 2022 May 04; 157(5):691-700. PubMed ID: 34664628 [Abstract] [Full Text] [Related]
34. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome. El Ghannam D, Taalab MM, Ghazy HF, Eneen AF. Blood Cells Mol Dis; 2014 May 04; 53(1-2):61-6. PubMed ID: 24512939 [Abstract] [Full Text] [Related]
35. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome. Volkert S, Kohlmann A, Schnittger S, Kern W, Haferlach T, Haferlach C. Genes Chromosomes Cancer; 2014 May 04; 53(5):402-10. PubMed ID: 24493299 [Abstract] [Full Text] [Related]
38. Mutational profiling of myeloid neoplasms associated genes may aid the diagnosis of acute myeloid leukemia with myelodysplasia-related changes. Yu J, Du Y, Jalil A, Ahmed Z, Mori S, Patel R, Varela JC, Chang CC. Leuk Res; 2021 Nov 04; 110():106701. PubMed ID: 34481124 [Abstract] [Full Text] [Related]
39. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype. Prats-Martín C, Burillo-Sanz S, Morales-Camacho RM, Pérez-López O, Suito M, Vargas MT, Caballero-Velázquez T, Carrillo-Cruz E, González J, Bernal R, Pérez-Simón JA. Cancer Med; 2020 Jun 04; 9(11):3637-3646. PubMed ID: 32216059 [Abstract] [Full Text] [Related]
40. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, Garcia-Manero G, Vadhan-Raj S, Hoehn D, Medeiros LJ, Yin CC. Cancer; 2012 Jun 01; 118(11):2879-88. PubMed ID: 22038701 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]